Abstract
Studies that evaluate the influence of gastric bypass (RYGP) on bone mass are limited to short-term follow-up. We analysed changes in bone mineral density (BMD) three years after surgery and evaluated the main determinants of the development of bone disease. Prospective study of 59 morbidly obese white women aged 46 ± 8 years. BMD scanning using DEXA and plasma determinations of calcium, parathyroid hormone, 25-hydroxyvitamin D and insulin-like growth factor-I were made prior, at 12 months and 3 years after surgery. In the first postoperative year BMD decreased at femoral neck (FN) 10.2 % and in the lumbar spine (LS) 3.2 %, in the third year it additionally decreased 2.7 % and 3.1 %, respectively. BMD at both sites remained above the values of women of the same age. In the follow-up, 1.7 % developed osteoporosis at FN and 6.8 % at LS. Patients with bone disease were older, the percentage of women with menopause was greater in this group and had lower initial and final values of lean mass. The percentage of BMD loss at FN remained positively associated with the percentage of lean mass loss [β 0.304, p = 0.045], and menopause [β 0.337, p = 0.025]. Major osteoporotic fracture and hip fracture risk was low even in menopausal patients (3.1 % and 0.40 %, respectively). After RYGP menopausal women and those with greater lean mass loss are at higher risk of BMD loss but progression to osteoporosis is uncommon and the risk of fracture is low.
References
De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330–8.
Ensurd KE, Lipschutz RC, Cauley JA, et al. Body size and hip fracture risk in older women—a prospective study. Am J Med. 1997;103:274–80.
Revilla M, Villa LF, Sanchez-Atrio A, et al. Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int. 1997;61:134–8.
Ricci TA, Heymsfield SB, Pierson RN, et al. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr. 2001;73:347–52.
Lean JM, Jagger CJ, Chambers TJ, et al. Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation. Am J Physiol. 1995;268:E318–22.
Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int. 1996;59:492–5.
Cornish J, Callon KE, Cooper GJS, et al. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun. 1995;207:133–9.
Cornish J, Callon KE, Bava U, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002;175:405–15.
Gómez-Ambrosi J, Rodríguez A, Catalán V, et al. The bone-adipose axis in obesity and weight loss. Obes Surg. 2008;18:1134–43.
Gómez JM, Vilarrasa N, Masdevall C, et al. Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg. 2009;19:345–50.
Vilarrasa N, Gómez JM, Masdevall C, et al. Study of the relationship between adiponectin, interleukin-18, ghrelin and bone mineral density in morbidly obese women after gastric bypass. Endocrinol nutr. 2009;56:355–60.
Coates PS, Fernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turn-over and a decrease in bone mass. J Clin Endocrinol Metab. 2004;89:1061–5.
Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density following gastric bypass surgery is associated with extend of weight loss. J Clin Endocrinol Metab. 2008;93:3735–40.
Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2009;19:41–6.
Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone and vitamin D. J Gastrointest Surg. 2005;9:1106–10.
Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–7.
Valderas JP, Velasco S, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y Gastric bypass. Obes Surg. 2009;19:1132–8.
Mahdy T, Atia S, Farid M, et al. Effect of Roux-en-Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008;18:1526–31.
Vilarrasa N, Gomez JM, Elio I, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg. 2009;19:860–6.
De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57–61.
Hamoui N, Kim K, Anthone G, et al. The significance of elevated levels of parathyroid hormone in patient with morbid obesity before and after surgery. Arch Surg. 2003;138:891–7.
Goldner WS, O’Dorisio TM, Dillon JS, et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002;12:685–92.
Slater GH, Ren CF, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55.
Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at 6 and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab. 2010;95:159–66.
Kanis JA, Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone. 2009;44:734–43.
Kanis JA, Mc Closkey E, Johansson H, et al. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010;21 suppl 2:S 407–13.
Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg. 1997;7:149–57.
World Health Organization. Obesity: preventing and managing the global epidemic. In: Report on a WHO consultation on obesity. WHO/NUT/NCD/98.1. Geneva, Switzerland: World Health Organization; 3–5 June, 1997.
Alonso GC, Curiel MD, Carranza FH, et al. Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000;11:714–20.
Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–81.
Villareal DT, Citivelli R, Chines A, et al. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab. 1991;72:628–34.
Thomas MK, Lloyd-Jones DM, Thadhani RI. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–83.
Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009;24:675–80.
Gjesdal CG, Halse JL, Eide GE, et al. Impact of lean mass and fat mass on bone mineral density: The Hordaland Health study. Maturitas. 2008;59:191–200.
Rendina D, Gianfrancesco F, De Filippo G, et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol. 2010;163:165–72.
El-Kadre LJ, Rocha PR, de Almeida Tinoco AC. Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric by-pass. Obes Surg. 2004;14:1062–6.
Diniz MF, Diniz MT, Sanches SR, et al. Elevated serum paratohormone after Roux-en-Y gastric by-pass. Obes Surg. 2004;14:1222–6.
Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007;21:1393–6.
Zofkova I. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res. 2003;52:657–79.
Collins D, Woods A, Herd R, et al. Insulin-like growth factor-I and bone mineral density. Bone. 1998;23:13–6.
Van Loan MD, Johnson HL, Barbieri TF. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr. 1998;67:734–8.
Tothill P, Hannan WJ, Cowen S, et al. Anomalies in the measurement of changes in total-body bone mineral by dual-energy X-ray absorptiometry during weight change. J Bone Miner Res. 1997;12:1908–21.
Acknowledgments
This study was supported by the CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), a project of Instituto de Salud Carlos III, ISCIII.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vilarrasa, N., San José, P., García, I. et al. Evaluation of Bone Mineral Density Loss in Morbidly Obese Women After Gastric Bypass: 3-Year Follow-Up. OBES SURG 21, 465–472 (2011). https://doi.org/10.1007/s11695-010-0338-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-010-0338-1